The goal of this study is to identify the platelet defect responsible for the bleeding in families from our inherited platelet disorders Israeli-Palestinian registry. The investigators plan to characterize platelet proteome expression after removing high abundance proteins. The investigators will compare the proteome of sick and healthy members of families with inherited platelet disorders, and identify and validate structural proteins, signaling cascades and biomarkers for detection and diagnosis of unknown platelet disorders. The investigators expect to discover new key findings that allow better understanding of human platelet function and allow better diagnosis and treatment of patients with inherited platelet function disorders.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
4
Hadassah Medical Organization
Jerusalem, Israel
Levels of detectable platelet proteins
Characterize platelet proteome expression profile
Time frame: 2014-2015 (1 year)
Changes in protein expression from sick and healthy platelets
Analysis of platelet proteome of sick and healthy members of families with inherited platelet disorders
Time frame: 2015-2019 (4 years)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.